Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study.

Margaret May Redfield, Richard J. Rodeheffer, Steven J. Jacobsen, Douglas W. Mahoney, Kent R Bailey, John C Jr. Burnett

Research output: Contribution to journalArticle

237 Citations (Scopus)

Abstract

BACKGROUND: Preclinical systolic or diastolic dysfunction is associated with increased morbidity and mortality. We postulated that plasma brain natriuretic peptide (BNP) might serve as a biomarker for preclinical ventricular dysfunction (PCVD) but that the discriminatory values for BNP may vary with age and sex. METHODS AND RESULTS: We measured BNP, systolic and diastolic ventricular function, and clinical parameters in 2042 randomly selected residents of Olmsted County, Minn, aged 45 years or older. For preclinical systolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with more severe (0.82 to 0.92) than any (0.51 to 0.74) systolic dysfunction and were similar in men and women and in younger and older persons. For preclinical diastolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with moderate-to-severe (0.74 to 0.79) than any (0.52 to 0.68) diastolic dysfunction and were similar regardless of age or sex. Optimal discriminatory values of BNP varied with age and sex. Considering the prevalence of preclinical systolic or diastolic dysfunction and the predictive characteristics observed, using BNP to screen for PCVD would necessitate echo in 10% to 40% of those screened, with most confirmatory echocardiograms being negative, and would miss 10% to 60% of those affected. CONCLUSIONS: BNP is a suboptimal screening test for PCVD in the population.

Original languageEnglish (US)
Pages (from-to)3176-3181
Number of pages6
JournalCirculation
Volume109
Issue number25
StatePublished - Jun 29 2004

Fingerprint

Brain Natriuretic Peptide
Ventricular Dysfunction
ROC Curve
Ventricular Function
Biomarkers
Morbidity
Mortality
Population

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction : a community-based study. / Redfield, Margaret May; Rodeheffer, Richard J.; Jacobsen, Steven J.; Mahoney, Douglas W.; Bailey, Kent R; Burnett, John C Jr.

In: Circulation, Vol. 109, No. 25, 29.06.2004, p. 3176-3181.

Research output: Contribution to journalArticle

@article{0e63314b68bc4e92a053f0156765ade1,
title = "Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study.",
abstract = "BACKGROUND: Preclinical systolic or diastolic dysfunction is associated with increased morbidity and mortality. We postulated that plasma brain natriuretic peptide (BNP) might serve as a biomarker for preclinical ventricular dysfunction (PCVD) but that the discriminatory values for BNP may vary with age and sex. METHODS AND RESULTS: We measured BNP, systolic and diastolic ventricular function, and clinical parameters in 2042 randomly selected residents of Olmsted County, Minn, aged 45 years or older. For preclinical systolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with more severe (0.82 to 0.92) than any (0.51 to 0.74) systolic dysfunction and were similar in men and women and in younger and older persons. For preclinical diastolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with moderate-to-severe (0.74 to 0.79) than any (0.52 to 0.68) diastolic dysfunction and were similar regardless of age or sex. Optimal discriminatory values of BNP varied with age and sex. Considering the prevalence of preclinical systolic or diastolic dysfunction and the predictive characteristics observed, using BNP to screen for PCVD would necessitate echo in 10{\%} to 40{\%} of those screened, with most confirmatory echocardiograms being negative, and would miss 10{\%} to 60{\%} of those affected. CONCLUSIONS: BNP is a suboptimal screening test for PCVD in the population.",
author = "Redfield, {Margaret May} and Rodeheffer, {Richard J.} and Jacobsen, {Steven J.} and Mahoney, {Douglas W.} and Bailey, {Kent R} and Burnett, {John C Jr.}",
year = "2004",
month = "6",
day = "29",
language = "English (US)",
volume = "109",
pages = "3176--3181",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "25",

}

TY - JOUR

T1 - Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction

T2 - a community-based study.

AU - Redfield, Margaret May

AU - Rodeheffer, Richard J.

AU - Jacobsen, Steven J.

AU - Mahoney, Douglas W.

AU - Bailey, Kent R

AU - Burnett, John C Jr.

PY - 2004/6/29

Y1 - 2004/6/29

N2 - BACKGROUND: Preclinical systolic or diastolic dysfunction is associated with increased morbidity and mortality. We postulated that plasma brain natriuretic peptide (BNP) might serve as a biomarker for preclinical ventricular dysfunction (PCVD) but that the discriminatory values for BNP may vary with age and sex. METHODS AND RESULTS: We measured BNP, systolic and diastolic ventricular function, and clinical parameters in 2042 randomly selected residents of Olmsted County, Minn, aged 45 years or older. For preclinical systolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with more severe (0.82 to 0.92) than any (0.51 to 0.74) systolic dysfunction and were similar in men and women and in younger and older persons. For preclinical diastolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with moderate-to-severe (0.74 to 0.79) than any (0.52 to 0.68) diastolic dysfunction and were similar regardless of age or sex. Optimal discriminatory values of BNP varied with age and sex. Considering the prevalence of preclinical systolic or diastolic dysfunction and the predictive characteristics observed, using BNP to screen for PCVD would necessitate echo in 10% to 40% of those screened, with most confirmatory echocardiograms being negative, and would miss 10% to 60% of those affected. CONCLUSIONS: BNP is a suboptimal screening test for PCVD in the population.

AB - BACKGROUND: Preclinical systolic or diastolic dysfunction is associated with increased morbidity and mortality. We postulated that plasma brain natriuretic peptide (BNP) might serve as a biomarker for preclinical ventricular dysfunction (PCVD) but that the discriminatory values for BNP may vary with age and sex. METHODS AND RESULTS: We measured BNP, systolic and diastolic ventricular function, and clinical parameters in 2042 randomly selected residents of Olmsted County, Minn, aged 45 years or older. For preclinical systolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with more severe (0.82 to 0.92) than any (0.51 to 0.74) systolic dysfunction and were similar in men and women and in younger and older persons. For preclinical diastolic dysfunction, the areas under the receiver operating characteristics curve were higher for those with moderate-to-severe (0.74 to 0.79) than any (0.52 to 0.68) diastolic dysfunction and were similar regardless of age or sex. Optimal discriminatory values of BNP varied with age and sex. Considering the prevalence of preclinical systolic or diastolic dysfunction and the predictive characteristics observed, using BNP to screen for PCVD would necessitate echo in 10% to 40% of those screened, with most confirmatory echocardiograms being negative, and would miss 10% to 60% of those affected. CONCLUSIONS: BNP is a suboptimal screening test for PCVD in the population.

UR - http://www.scopus.com/inward/record.url?scp=4143128382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143128382&partnerID=8YFLogxK

M3 - Article

C2 - 15184280

AN - SCOPUS:4143128382

VL - 109

SP - 3176

EP - 3181

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 25

ER -